IDH1 and central nervous system cancer: IDHmut glioma–induced spikes in spheroids were reduced by both a first-generation IDH1mut inhibitor, AGI5198 (P < 0.0001), and a second-generation IDH1/2 mutant inhibitor, AG881 (P = 0.0008) (Figure 4, D and E).